Search Results - DOWNSTAGE

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib by L. Barbier, F. Muscari, S. Le Guellec, A. Pariente, P. Otal, B. Suc

    Published in International Journal of Hepatology (2011-01-01)
    “…Conclusion. Sorafenib can downstage hepatocellular carcinoma and thus could represent a bridge to surgery. …”
    Get full text
    Article
  6. 6
  7. 7
  8. 8

    Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis by Diama Bhadra Vale, Cassio Cardoso Filho, Julia Yoriko Shinzato, Fernanda Servidoni Spreafico, Partha Basu, Luiz Carlos Zeferino

    Published in BMC Cancer (2019-05-01)
    “…Conclusions Breast cancer cases are diagnosed mainly at early stages, and approximately one-third of cases are younger than 50 years old. Downstaging has been shown. Opportunistic screening may have supported these results. …”
    Get full text
    Article
  9. 9
  10. 10

    Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma by Alexander Villalobos, William Wagstaff, Mian Guo, James Zhang, Zachary Bercu, Morgan J. Whitmore, Mircea M Cristescu, Bill S. Majdalany, Joel Wedd, Mehmet Akce, Joseph Magliocca, Marty T. Sellers, Nima Kokabi

    “…This study aims to identify clinical and imaging prognosticators associated with the successful bridging or downstaging to liver transplantation (LT) in patients undergoing Yttrium-90 radioembolization (Y90-RE) for hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  11. 11

    The Real Impact of Bridging or Downstaging on Survival Outcomes after Liver Transplantation for Hepatocellular Carcinoma by Sunyoung Lee, Kyoung Won Kim, Gi-Won Song, Jae Hyun Kwon, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Gil-Chun Park, Sung-Gyu Lee

    Published in Liver Cancer (2020-10-01)
    “…Introduction: There is no consensus regarding selection criteria on liver transplantation (LT) for hepatocellular carcinoma (HCC), especially for living donor liver transplantation, although emerging evidence has been found for the effectiveness of bridging or downstaging. Objective: We evaluated the long-term outcomes of patients who underwent LT with or without bridging or downstaging for HCC. …”
    Get full text
    Article
  12. 12
  13. 13

    Successful Downstaging of High Rectal and Recto-Sigmoid Cancer by Neo-Adjuvant Chemo-Radiotherapy by Brian O'neill F.F.R.R.C.S.I., Gina Brown, Andrew Wotherspoon, Sarah Burton, Andy Norman, Diana Tait

    Published in Clinical Medicine Insights: Oncology (2008-01-01)
    “…The purpose of this study is to demonstrate the feasibility and downstaging of treating locally advanced tumours from high rectum to distal sigmoid with preoperative chemoradiotherapy (CRT). …”
    Get full text
    Article
  14. 14
  15. 15

    Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy by Kuo Li, Xiaonian Cao, Bo Ai, Han Xiao, Quanfu Huang, Zheng Zhang, Qian Chu, Li Zhang, Xiaofang Dai, Yongde Liao

    Published in Thoracic Cancer (2021-08-01)
    “…Targeted therapy improve the survival in these patients, but acquired drug resistance will inevitably occur. If tumor downstaging is achieved after targeted therapy, could surgical resection before drug resistance improve clinical benefits for patients with advanced NSCLC? …”
    Get full text
    Article
  16. 16

    Body composition: a crucial factor in downstaging and postoperative complications of neoadjuvant chemotherapy for gastric cancer by Zhuanmei Jin, Min Chen, Qinglin Yang, Changyu Yao, Yanting Li, Taohua Zhang, Min Lai, Shuangxi Li, Lipeng Ding, Wenzhen Yuan, Wenzhen Yuan

    Published in Frontiers in Nutrition (2024-11-01)
    “…Based on the presence of a post-NAC downstaging period and postoperative complications, we categorized the patients into group A (downstaging without complications), group B (downstaging with complications), group C (non-downstaging with complications), and group D (non-downstaging without complications). …”
    Get full text
    Article
  17. 17
  18. 18
  19. 19

    Tumor downstaging and therapeutic pathomorphosis in rectal cancer patients receiving combination therapy with various polyradiomodification regimens by O. A. Vlasov, Yu. A. Barsukov, S. I. Tkachev, S. S. Gordeev, V. F. Tsaryuk, V. A. Aliev

    “…Objective: to evaluate therapeutic pathomorphosis and Tand N-downstaging in response to various polyradiomodification regimens used in the combination therapy for rectal cancer.Materials and methods. …”
    Get full text
    Article
  20. 20

Search Tools: